Cost-effectiveness of psychedelic-assisted therapies for depression and post-traumatic stress disorder: A systematic review
Paper. Sheikhrobat MV, Jaberi N, Tahmasebi-Ghorrabi A et al.. Psychiatry Research, 13 Nov 2026.
Tags: Review, Psilocybin, MDMA, Depression, PTSD.
systematic review of seven economic evaluations: MDMA-assisted therapy for PTSD came out broadly cost-effective, with thinner data for psilocybin in depression
Read the original
PsyDAO home — the network globe
Vision
DeSci Dictionary — psychedelic science & web3 glossary
Treasury — live DAO holdings
Projects — funded psychedelic science & art
Events
Governance, proposals & voting
Science: weekly digest, paper library and research chat
Shop — apparel, art & artifacts
Idea board — pitch an idea for funding
PsyDAO whitepaper (PDF)